![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: C1D |
Gene summary for C1D |
![]() |
Gene information | Species | Human | Gene symbol | C1D | Gene ID | 10438 |
Gene name | C1D nuclear receptor corepressor | |
Gene Alias | LRP1 | |
Cytomap | 2p14 | |
Gene Type | protein-coding | GO ID | GO:0000460 | UniProtAcc | Q13901 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10438 | C1D | LZE2T | Human | Esophagus | ESCC | 1.99e-10 | 1.21e+00 | 0.082 |
10438 | C1D | LZE4T | Human | Esophagus | ESCC | 8.54e-35 | 9.38e-01 | 0.0811 |
10438 | C1D | LZE5T | Human | Esophagus | ESCC | 4.02e-07 | 5.71e-01 | 0.0514 |
10438 | C1D | LZE7T | Human | Esophagus | ESCC | 3.64e-10 | 6.87e-01 | 0.0667 |
10438 | C1D | LZE8T | Human | Esophagus | ESCC | 1.23e-13 | 5.19e-01 | 0.067 |
10438 | C1D | LZE20T | Human | Esophagus | ESCC | 1.98e-07 | 3.58e-01 | 0.0662 |
10438 | C1D | LZE22D1 | Human | Esophagus | HGIN | 8.91e-06 | 2.70e-01 | 0.0595 |
10438 | C1D | LZE22T | Human | Esophagus | ESCC | 3.17e-09 | 6.34e-01 | 0.068 |
10438 | C1D | LZE24T | Human | Esophagus | ESCC | 3.36e-30 | 8.80e-01 | 0.0596 |
10438 | C1D | LZE21T | Human | Esophagus | ESCC | 2.19e-09 | 6.68e-01 | 0.0655 |
10438 | C1D | LZE6T | Human | Esophagus | ESCC | 4.51e-09 | 4.67e-01 | 0.0845 |
10438 | C1D | P1T-E | Human | Esophagus | ESCC | 1.48e-10 | 7.86e-01 | 0.0875 |
10438 | C1D | P2T-E | Human | Esophagus | ESCC | 8.79e-59 | 9.53e-01 | 0.1177 |
10438 | C1D | P4T-E | Human | Esophagus | ESCC | 2.49e-54 | 1.22e+00 | 0.1323 |
10438 | C1D | P5T-E | Human | Esophagus | ESCC | 1.20e-47 | 8.69e-01 | 0.1327 |
10438 | C1D | P8T-E | Human | Esophagus | ESCC | 5.12e-58 | 8.93e-01 | 0.0889 |
10438 | C1D | P9T-E | Human | Esophagus | ESCC | 6.21e-35 | 7.23e-01 | 0.1131 |
10438 | C1D | P10T-E | Human | Esophagus | ESCC | 2.97e-57 | 9.14e-01 | 0.116 |
10438 | C1D | P11T-E | Human | Esophagus | ESCC | 7.69e-27 | 9.68e-01 | 0.1426 |
10438 | C1D | P12T-E | Human | Esophagus | ESCC | 3.61e-58 | 1.05e+00 | 0.1122 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001907920 | Oral cavity | OSCC | viral genome replication | 95/7305 | 131/18723 | 6.35e-15 | 4.02e-13 | 95 |
GO:005254720 | Oral cavity | OSCC | regulation of peptidase activity | 255/7305 | 461/18723 | 5.78e-13 | 2.75e-11 | 255 |
GO:004440320 | Oral cavity | OSCC | biological process involved in symbiotic interaction | 173/7305 | 290/18723 | 6.80e-13 | 3.19e-11 | 173 |
GO:005079220 | Oral cavity | OSCC | regulation of viral process | 109/7305 | 164/18723 | 8.95e-13 | 4.10e-11 | 109 |
GO:00162417 | Oral cavity | OSCC | regulation of macroautophagy | 96/7305 | 141/18723 | 2.33e-12 | 9.75e-11 | 96 |
GO:00161979 | Oral cavity | OSCC | endosomal transport | 141/7305 | 230/18723 | 5.40e-12 | 2.06e-10 | 141 |
GO:00070335 | Oral cavity | OSCC | vacuole organization | 115/7305 | 180/18723 | 1.11e-11 | 4.00e-10 | 115 |
GO:001095220 | Oral cavity | OSCC | positive regulation of peptidase activity | 123/7305 | 197/18723 | 2.12e-11 | 7.21e-10 | 123 |
GO:003298410 | Oral cavity | OSCC | protein-containing complex disassembly | 136/7305 | 224/18723 | 3.42e-11 | 1.13e-09 | 136 |
GO:005160410 | Oral cavity | OSCC | protein maturation | 170/7305 | 294/18723 | 3.97e-11 | 1.28e-09 | 170 |
GO:005254820 | Oral cavity | OSCC | regulation of endopeptidase activity | 235/7305 | 432/18723 | 4.35e-11 | 1.40e-09 | 235 |
GO:000690019 | Oral cavity | OSCC | vesicle budding from membrane | 49/7305 | 61/18723 | 4.73e-11 | 1.50e-09 | 49 |
GO:004852417 | Oral cavity | OSCC | positive regulation of viral process | 51/7305 | 65/18723 | 9.56e-11 | 2.90e-09 | 51 |
GO:00164829 | Oral cavity | OSCC | cytosolic transport | 106/7305 | 168/18723 | 2.08e-10 | 5.90e-09 | 106 |
GO:000989519 | Oral cavity | OSCC | negative regulation of catabolic process | 180/7305 | 320/18723 | 2.44e-10 | 6.86e-09 | 180 |
GO:003133020 | Oral cavity | OSCC | negative regulation of cellular catabolic process | 152/7305 | 262/18723 | 3.04e-10 | 8.28e-09 | 152 |
GO:00069037 | Oral cavity | OSCC | vesicle targeting | 38/7305 | 45/18723 | 4.49e-10 | 1.19e-08 | 38 |
GO:00516509 | Oral cavity | OSCC | establishment of vesicle localization | 101/7305 | 161/18723 | 8.79e-10 | 2.17e-08 | 101 |
GO:001063918 | Oral cavity | OSCC | negative regulation of organelle organization | 190/7305 | 348/18723 | 2.12e-09 | 4.97e-08 | 190 |
GO:19033227 | Oral cavity | OSCC | positive regulation of protein modification by small protein conjugation or removal | 88/7305 | 138/18723 | 3.24e-09 | 7.39e-08 | 88 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0301810 | Esophagus | HGIN | RNA degradation | 27/1383 | 79/8465 | 7.73e-05 | 9.00e-04 | 7.15e-04 | 27 |
hsa0301815 | Esophagus | HGIN | RNA degradation | 27/1383 | 79/8465 | 7.73e-05 | 9.00e-04 | 7.15e-04 | 27 |
hsa03018 | Liver | Cirrhotic | RNA degradation | 44/2530 | 79/8465 | 1.43e-06 | 1.65e-05 | 1.02e-05 | 44 |
hsa030181 | Liver | Cirrhotic | RNA degradation | 44/2530 | 79/8465 | 1.43e-06 | 1.65e-05 | 1.02e-05 | 44 |
hsa030182 | Liver | HCC | RNA degradation | 58/4020 | 79/8465 | 2.29e-06 | 2.19e-05 | 1.22e-05 | 58 |
hsa030183 | Liver | HCC | RNA degradation | 58/4020 | 79/8465 | 2.29e-06 | 2.19e-05 | 1.22e-05 | 58 |
hsa030189 | Oral cavity | OSCC | RNA degradation | 59/3704 | 79/8465 | 2.05e-08 | 1.91e-07 | 9.70e-08 | 59 |
hsa0301814 | Oral cavity | OSCC | RNA degradation | 59/3704 | 79/8465 | 2.05e-08 | 1.91e-07 | 9.70e-08 | 59 |
hsa0301823 | Oral cavity | LP | RNA degradation | 39/2418 | 79/8465 | 6.98e-05 | 4.38e-04 | 2.83e-04 | 39 |
hsa0301833 | Oral cavity | LP | RNA degradation | 39/2418 | 79/8465 | 6.98e-05 | 4.38e-04 | 2.83e-04 | 39 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
C1D | SNV | Missense_Mutation | c.109T>C | p.Ser37Pro | p.S37P | Q13901 | protein_coding | deleterious(0.02) | possibly_damaging(0.798) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
C1D | SNV | Missense_Mutation | c.7N>A | p.Gly3Ser | p.G3S | Q13901 | protein_coding | tolerated(0.9) | benign(0) | TCGA-AZ-6607-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD | |
C1D | SNV | Missense_Mutation | c.32N>T | p.Pro11Leu | p.P11L | Q13901 | protein_coding | deleterious(0) | possibly_damaging(0.661) | TCGA-DM-A28F-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
C1D | SNV | Missense_Mutation | novel | c.4N>A | p.Ala2Thr | p.A2T | Q13901 | protein_coding | deleterious(0.04) | probably_damaging(0.976) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
C1D | SNV | Missense_Mutation | c.192N>G | p.Asn64Lys | p.N64K | Q13901 | protein_coding | deleterious(0) | probably_damaging(0.927) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
C1D | SNV | Missense_Mutation | novel | c.305A>T | p.Asp102Val | p.D102V | Q13901 | protein_coding | deleterious(0) | benign(0.17) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
C1D | insertion | Frame_Shift_Ins | novel | c.222dupA | p.Gly75ArgfsTer3 | p.G75Rfs*3 | Q13901 | protein_coding | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD | ||
C1D | insertion | Frame_Shift_Ins | rs776000138 | c.359_360insA | p.Asn120LysfsTer17 | p.N120Kfs*17 | Q13901 | protein_coding | TCGA-BK-A13B-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | ||
C1D | SNV | Missense_Mutation | novel | c.403N>G | p.Asn135Asp | p.N135D | Q13901 | protein_coding | tolerated(0.3) | benign(0) | TCGA-L4-A4E5-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
C1D | SNV | Missense_Mutation | rs775915228 | c.27N>A | p.Asp9Glu | p.D9E | Q13901 | protein_coding | tolerated(0.37) | benign(0.017) | TCGA-CV-5979-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |